Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of BR1017A and BR1017B in essential hypertension with primary hypercholesterolemia has completed its…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Hypercholesterolemia

Drugs mentioned

• BR1017A
• BR1017B

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension, Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED